| Cat.No. | Name | Information |
|---|---|---|
| M45241 | Ecallantide | Ecallantide is a potent, selective inhibitor of recombinant plasma kinin releasing enzyme that inhibits bradykinin production. |
| M45240 | OK-101 | OK-101 is a lipid-coupled chemokine peptide agonist of the ChemR23 g-protein-coupled receptor that can be used in studies related to neuropathic corneal pain (NCP). |
| M45231 | Omomyc | Omomyc is a cell-penetrating peptide derived from the bHLH structural domain of Myc. When expressed in cells, Omomyc inhibits C-Myc-mediated transcription and suppresses cell proliferation.Omomyc competes with C-Myc for binding to Max, resulting in the formation of the Omomyc/Max complex, which competes with the endogenous c-Myc/Max heterodimer and ultimately inhibits transcriptional activation resulting in Myc target genes involved in proliferation and metabolism. |
| M45154 | PN-943 | PN-943 is a potentially first-in-class, orally active, specific α4β7 integrin antagonist peptide for studies related to inflammatory bowel disease (IBD). |
| M45132 | Palopegteriparatide | Palopegteriparatide is a long-acting precursor compound of parathyroid hormone (PTH), as well as a calcium-sensitive receptor (CaSR) antagonist, and a parathyroid hormone receptor (PTH1R) modulator, and may be used in studies related to hypoparathyroidism (HP). |
| M45130 | NNC0385-0434 | NNC0385-0434 is a peptide based on the epidermal growth-factor-like domain A of the human LDLR peptide. NNC0385-0434 competitively binds free PCSK9 and subsequently prevents PCSK9 binding to the LDLR. NNC0385-0434 is an orally active peptide small molecule PCSK9 inhibitor for atherosclerosis-related studies. |
| M45056 | RLS-0071 | RLS-0071RLS-0071 is a dual-targeted peptide that modulates humoral and cellular immunity by inhibiting neutrophil effectors, including myeloperoxidase and neutrophil extracellular net trap (NET) formation. |
| M43909 | LSTA1 | LSTA1 is a novel tumor-targeting penetrating peptide that enables compounds to penetrate tumors more efficiently and accumulate in tumors by activating tumor-specific transport systems. It can be used in studies related to solid tumors. |
| M43811 | IIAEK | IIAEK is a novel cholesterol-lowering pentapeptide derived from bovine milk β-lactoglobulin that targets intestinal alkaline phosphatase (IAP) and improves cholesterol metabolism through the specific activation of IAP and down-regulation of ABCA1. Sequence: Ile-Ile-Ala-Glu-Lys |
| M43365 | YYRADDA | YYRADDA is a polypeptide. |
| M43364 | Serylleucine | Serylleucine is a dipeptide. |
| M43363 | Propionylglycine | Propionylglycine is a peptide. |
| M43362 | NMB-1 | NMB-1 is a conopeptide analogue. |
| M43361 | Minigastrin | Minigastrin is an acidic peptide. |
| M43360 | Pyr-Gly | Pyr-Gly is an inhibitory peptide. |
| M43359 | SIGSLAK | SIGSLAK has the active site of E. |
| M43358 | CLIVILSPFVKT TFA | CLIVILSPFVKT TFA is a polypeptide. |
| M43357 | Tri-aspartic acid | Tri-aspartic acid is a tripeptide. |
| M43356 | EA2 | EA2 is a biological active peptide. |
| M43355 | HD5 | HD5 is a biological active peptide. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
